Prostamax is a short peptide bioregulator originally isolated from prostate tissue, developed as part of a broader family of cytomedine-derived peptides researched extensively by the St Petersburg Institute of Bioregulation and Gerontology. Like other peptide bioregulators in this class, Prostamax is believed to function by interacting with specific DNA sequences in prostate cells, potentially influencing gene expression and supporting tissue homeostasis at a cellular level.
In preclinical research settings, Prostamax has been investigated for its potential role in prostate tissue regulation, cellular turnover, and the maintenance of normal glandular function. Studies have explored its relevance in models of age-related prostate changes and tissue-specific cellular dysfunction.
For optimal stability, store lyophilised product at -20°C, protected from light and moisture. Once reconstituted, use promptly or store at 4°C for short-term use.
Molecular Formula
C₄₁H₇₀N₁₂O₁₄
Molecular Weight
963.1 g/mol
Purity
>98%
CAS Number
N/A
Form
Lyophilised Powder
Research Applications
Prostate tissue regulation, Cellular gene expression, Age-related glandular research, Tissue homeostasis, Peptide bioregulator studies
For research purposes only. Not for human use.
Reviews
There are no reviews yet.